Skip Navigation

European Heart Journal 2004 25(13):1179; doi:10.1016/j.ehj.2004.01.026
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van de Laar, F. A
Right arrow Articles by Lucassen, P. L.B.J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van de Laar, F. A
Right arrow Articles by Lucassen, P. L.B.J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

No evidence for a reduction of myocardial infarctions by acarbose

Floris A van de Laar* and Peter L.B.J Lucassen

Department of General Practice, University Medical Centre Nijmegen, 229 HAG, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

* Corresponding author. Tel.: +31-24-3614411; fax: +31-24-3541862
E-mail address: f.vandelaar@hag.umcn.nl

The first 10% of the full text of this article appears below.

With great interest we read the article of Hanefeld et al., in which a meta-analysis of seven randomised controlled trials was presented. This meta-analysis compared acarbose with placebo in patients with type 2 diabetes with respect to the incidence of cardiovascular events.1 The conclusion that acarbose can prevent myocardial infarctions . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
C. Bianchi, R. Miccoli, G. Daniele, G. Penno, and S. Del Prato
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Diabetes Care, November 1, 2009; 32(suppl_2): S342 - S348.
[Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
P. N Bavenholm and S. Efendic
Postprandial hyperglycaemia and vascular damage - the benefits of acarbose
Diabetes and Vascular Disease Research, September 1, 2006; 3(2): 72 - 79.
[Abstract] [PDF]